Clinical Trial Update: Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients [Phase 1]

View source ↗

Summary

Phase 1 trial assessing how AZD1656 affects the pharmacokinetics and pharmacodynamics of warfarin in patients with Type 2 Diabetes Mellitus; the study is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656
• Warfarin (warfarin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED